Source Directory

Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011). Phage treatment of human infections. Bacteriophage, 1(2), 66–85.

Ackerman, J. (2012). The ultimate social network. Scientific American, 306(6), 36–43.

Ai, D., Huang, R., Wen, J., Li, C., Zhu, J., & Xia, L. C. (2017). Integrated metagenomic data analysis demonstrates that a loss of diversity in oral microbiota is associated with periodontitis. BMC Genomics, 18(S1), 1041.

Alekseyenko, A. V, Perez-Perez, G. I., De Souza, A., Strober, B., Gao, Z., Bihan, M., … Blaser, M. J. (2013). Community differentiation of the cutaneous microbiota in psoriasis. Microbiome, 1(1), 31.

Andersson, D. I., Hughes, D., & Kubicek-Sutherland, J. Z. (2016). Mechanisms and consequences of bacterial resistance to antimicrobial peptides. Drug Resistance Updates, 26, 43–57.

Bahar, A. A., & Ren, D. (2013). Antimicrobial peptides. Pharmaceuticals, 6(12), 1543–1575.

Barbut, F., & Meynard, J. L. (2002). Managing antibiotic associated diarrhoea. BMJ (Clinical Research Ed.), 324(7350), 1345–6.

Blaser, Martin J., Missing Microbes: How the Overuse of Antibiotics Is Fueling Our Modern Plagues, Henry Holt Verlag, New York, 2014

Blekhman, R., Goodrich, J. K., Huang, K., Sun, Q., Bukowski, R., Bell, J. T., … Clark, A. G. (2015). Host genetic variation impacts microbiome composition across human body sites. Genome Biology, 16(1), 191.

Bokulich, N. A., Subramanian, S., Faith, J. J., Gevers, D., Gordon, I., Knight, R., … Manuscript, A. (2013). Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. NIH Public Access. Genomics, 10(1), 151–170.

Briers, Y., & Lavigne, R. (2015). Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria. Future Microbiology, 10(3), 377–390.

Briers, Y., Walmagh, M., Grymonprez, B., Biebl, M., Pirnay, J. P., Defraine, V., … Lavigne, R. (2014). Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 58(7), 3774–3784.

Briers, Y., Walmagh, M., Puyenbroeck, V. Van, Cornelissen, A., Cenens, W., Aertsen, A., & Oliveira, H. (2014). Engineered Endolysin Based “ Artilysins ” To Combat Multidrug Resistant GramNegative pathogens. mBio, 5(4), 1–10.

Chen, Y., & Tsao, H. (2013). The skin microbiome: current perspectives and future challenges. Journal of the American Academy of Dermatology, 69(1), 143–155.

Christina, S., Ltg, M., Spies, S., Werle, K., Alice, B., Ltg, K., … Rabe, G. (2016). Was unsere Bakterien über uns verraten. Spektrum der Wissenschaft

Clemente, J. C., Pehrsson, E. C., Blaser, M. J., Sandhu, K., Gao, Z., Wang, B., … Dominguez-Bello, M. G. (2015). The microbiome of uncontacted Amerindians. Science Advances, 1(3), e1500183–e1500183.

Cooper, A. J., Weyrich, L. S., Dixit, S., & Farrer, A. G. (2015). The skin microbiome: Associations between altered microbial communities and disease. Australasian Journal of Dermatology, 56(4), 268–274.

Defraine, V., Schuermans, J., Grymonprez, B., Govers, S. K., Aertsen, A., Fauvart, M., … Briers, Y. (2016). Efficacy of artilysin art-175 against resistant and persistent acinetobacter baumannii. Antimicrobial Agents and Chemotherapy, 60(6), 3480–3488.

Dietert, R. R., & Silbergeld, E. K. (2015). Biomarkers for the 21st century: Listening to the microbiome. Toxicological Sciences, 144(2), 208–216.

Dye, C. (2014). After 2015: infectious diseases in a new era of health and development. Philos Trans R Soc Lond B Biol Sci, 369(1645), 20130426.

Gaskins, H. R. (1999). Developmental Microbial Ecology of the Neonata GIT. The American Journal of Clinical Nutrition, 69, 1035S–1045S.

Gerstmans, H., Rodriguez-Rubio, L., Lavigne, R., & Briers, Y. (2016). From endolysins to Artilysin(R)s: novel enzyme-based approaches to kill drug-resistant bacteria. Biochemical Society Transactions, 44(1), 123–128.

Grice, Elizabeth A. (Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, 20892–4442, U. ., & Segre, J. A. (2013). The skin microbiome. Nat Rev Microbiol, 9(4), 244–253.

Huang, B., Fettweis, J. M., Brooks, J. P., Jefferson, K. K., & Buck, G. A. (2014). The changing landscape of the vaginal microbiome. Clinics in Laboratory Medicine, 34(4), 747–761.

Hug, L. A., Baker, B. J., Anantharaman, K., Brown, C. T., Probst, A. J., Castelle, C. J., … Banfield, J. F. (2016). A new view of the tree of life. Nature Microbiology, 1(5), 1–6.

Indrio, F., Martini, S., Francavilla, R., Corvaglia, L., Cristofori, F., Mastrolia, S. A., … Loverro, G. (2017). Epigenetic Matters: The Link between Early Nutrition, Microbiome, and Long-term Health Development. Frontiers in Pediatrics, 5(August), 1–14.

Kashani, H. H., Schmelcher, M., Sabzalipoor, H., Hosseini, E. S., & Moniri, R. (2017). Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus : Current Status of Research and Novel Delivery Strategies.

Khanna, S., & Tosh, P. K. (2014). A clinician’s primer on the role of the microbiome in human health and disease. Mayo Clinic Proceedings, 89(1), 107–114.

Kong, H. H. (2015). Temporal shifts in the skin microbiome associated with disease flare and treatment in children with atopic dermatitis. Genome Research, 850–859.

Kong, H. H., & Segre, J. A. (2012). Skin microbiome: looking back to move forward. HHS Public Access, 132(3), 933–939.

Lederberg J, McCray AT ; Genealogical Treasury of Words. Scientist. 2001;15(7):8.

Lima-Ojeda, J. M., Rupprecht, R., & Baghai, T. C. (2017). “I am i and my bacterial circumstances”: Linking gut microbiome, neurodevelopment, and depression. Frontiers in Psychiatry, 8(AUG), 1–13.

Lloyd-Price, J., Abu-Ali, G., & Huttenhower, C. (2016). The healthy human microbiome. Genome Medicine, 8(1), 51.

Luke K Ursell, Jessica L Metcalf, Laura Wegener Parfrey, and R. K. (2013). Definig the Human Microbiome. NIH Manuscripts, 70(Suppl 1), 1–12.

Manuscript, A., & Wounds, C. (2012). Current Topics in Innate Immunity II, 946, 55–68.

Martín, R., Miquel, S., Langella, P., & Bermúdez-Humarán, L. G. (2014). The role of metagenomics in understanding the human microbiome in health and disease. Virulence, 5(3), 413–423.

Mcmahon, T., Zijl, P. C. M. Van, & Gilad, A. A. (2015). NIH Public Access, 27(3), 320–331.

Muszer, M., Noszczyńska, M., Kasperkiewicz, K., & Skurnik, M. (2015). Human Microbiome: When a Friend Becomes an Enemy. Archivum Immunologiae et Therapiae Experimentalis, 63(4), 287–298.

Nih, T., & Working, H. M. P. (2009). The NIH Human Microbiome Project. Genome Research, 19(12), 2317–2323.

Riiser, A. (2015). The human microbiome, asthma, and allergy. Allergy, Asthma & Clinical Immunology, 11(1), 35.

Roach, D. R., & Debarbieux, L. (2017). Phage therapy: awakening a sleeping giant. Emerging Topics in Life Sciences, 1(1), 93–103.

Rodríguez-Rubio, L., Chang, W. L., Gutiérrez, D., Lavigne, R., Martínez, B., Rodríguez, A., … García, P. (2016). “Artilysation” of endolysin λSa2lys strongly improves its enzymatic and antibacterial activity against streptococci. Scientific Reports, 6(June), 1–11.

Sender, R., Fuchs, S., & Milo, R. (2016). Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biology, 14(8), 1–14.

Schmelcher, M., Donovan, D. M., & Loessner, M. J. (2012). Bacteriophage endolysins as novel antimicrobials. Future Microbiology, 7(10), 1147–1171.

Schmelcher, M., & Loessner, M. J. (2016). Bacteriophage endolysins: Applications for food safety. Current Opinion in Biotechnology, 37(July), 76–87.

Smith, K. F., Goldberg, M., Rosenthal, S., Carlson, L., Chen, J., Chen, C., & Ramachandran, S. (2014). Global rise in human infectious disease outbreaks. Journal of The Royal Society Interface, 11(101), 20140950–20140950.

Steenbergen, J. N., Alder, J., Thorne, G. M., & Tally, F. P. (2005). Daptomycin: A lipopeptide antibiotic for the treatment of serious Gram-positive infections. Journal of Antimicrobial Chemotherapy, 55(3), 283–288.

Struzycka, I. (2014). The oral microbiome in dental caries. Polish Journal of Microbiology, 63(2), 127–135.

Thomas, F., Hehemann, J. H., Rebuffet, E., Czjzek, M., & Michel, G. (2011). Environmental and gut Bacteroidetes: The food connection. Frontiers in Microbiology, 2(MAY), 1–16.

Zaura, E., Nicu, E. A., Krom, B. P., & Keijser, B. J. F. (2014). Acquiring and maintaining a normal oral microbiome: current perspective. Frontiers in Cellular and Infection Microbiology, 4(June), 1–8.

Hojsak, I. (2017). Probiotics in Children: What Is the Evidence? Pediatric Gastroenterology, Hepatology & Nutrition,20(3), 139.

Cerdó, T., Ruíz, A., Suárez, A., & Campoy, C. (2017). Probiotic, prebiotic, and brain development. Nutrients,9(11), 1–19.

He, M., & Shi, B. (2017). Gut microbiota as a potential target of metabolic syndrome: The role of probiotics and prebiotics. Cell and Bioscience, 7(1), 1–14.

Holder, M. K., & Chassaing, B. (2018). Impact of food additives on the gut-brain axis. Physiology and Behavior, (February), 0–1.

Katan, M. B. (2012). Why the European food safety Authority was right to reject health claims for probiotics. Beneficial Microbes, 3(2), 85–89.

Lebeer, S., Bron, P. A., Marco, M. L., Van Pijkeren, J. P., O’Connell Motherway, M., Hill, C., … Klaenhammer, T. (2018). Identification of probiotic effector molecules: present state and future perspectives. Current Opinion in Biotechnology, 49(November 2017), 217–223.

Ouwehand, A. C. (2017). A review of dose-responses of probiotics in human studies. Beneficial Microbes, 8(2), 143–151.

Sanders, M. E., Benson, A., Lebeer, S., Merenstein, D. J., & Klaenhammer, T. R. (2018). Shared mechanisms among probiotic taxa: implications for general probiotic claims. Current Opinion in Biotechnology, 49(Figure 1), 207–216.

Shortt, C., Hasselwander, O., Meynier, A., Nauta, A., Fernández, E. N., Putz, P., … Antoine, J. M. (2018). Systematic review of the effects of the intestinal microbiota on selected nutrients and non-nutrients. European Journal of Nutrition, 57(1), 25–49.

Summer, A., Formaggioni, P., Franceschi, P., Frangia, F. Di, Righi, F., & Malacarne, M. (2017). Cheese as functional food: The example of parmigiano reggiano and grana padano. Food Technology and Biotechnology, 55(3), 277–289. b.

Thomas, F., Hehemann, J. H., Rebuffet, E., Czjzek, M., & Michel, G. (2011). Environmental and gut Bacteroidetes: The food connection. Frontiers in Microbiology, 2(MAY), 1–16.

Tytgat, H. L. P., Reunanen, J., Rasinkangas, P., Hendrickx, A. P. A., Laine, P. K., Paulin, L., …Vos, W. M. De. (2016). Lactobacillus rhamnosus, 82(19), 5756–5762.

Zinöcker, M. K., & Lindseth, I. A. (2018). The western diet–microbiome-host interaction and its role in metabolic disease. Nutrients, 10(3), 1–15.]

© Copyright 2018 - 2023 | MyMicrobiome
– The independent certification and research institute for our microbiome –

DISCLAIMER: Nothing on this site or blog is intended to provide medical advice, diagnosis or treatment.


By clicking "Accept all", you agree to cookies being stored on your local device. This improves navigation on the site, video content can be displayed and we can anonymously analyse whether the pages are being used as intended. All approvals are made in accordance with the provisions of the GDPR.

You are using an outdated browser. The website may not be displayed correctly. Close